Core Viewpoint - The announcement indicates that Ying'en Biotechnology-B (09606.HK) will be included in the Hang Seng Composite Index and the Stock Connect program starting September 8, 2025, reflecting strong market recognition of the company's performance and value [1] Group 1 - The inclusion in the Hang Seng Composite Index and Stock Connect signifies a significant endorsement from the capital market [1] - This move allows qualified investors from mainland China to directly invest in the company's shares listed on the Hong Kong Stock Exchange through the Shanghai Stock Exchange [1] - The anticipated inclusion is expected to broaden the company's investor base and potentially increase the trading liquidity of its shares [1]